Clinical trials
Phase 3 Fatigue trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 13 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Unknown status | 11 |
| Terminated | 7 |
| Recruiting | 7 |
| Withdrawn | 2 |
| Suspended | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 6 |
| Charite University, Berlin, Germany | 6 |
| M.D. Anderson Cancer Center | 5 |
| Azidus Brasil | 2 |
| ETOP IBCSG Partners Foundation | 2 |
| Eastern Cooperative Oncology Group | 2 |
| Eli Lilly and Company | 2 |
| Gynecologic Oncology Group | 2 |
| Harmony Biosciences Management, Inc. | 2 |
| MDVI, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatigue | 80 |
| Neoplasms | 10 |
| Breast Neoplasms | 9 |
| Pain | 7 |
| Multiple Myeloma | 5 |
| Sleep Wake Disorders | 5 |
| Hodgkin Disease | 4 |
| Multiple Sclerosis | 4 |
| Anemia | 3 |
| Blast Crisis | 3 |
Trials
Showing 26 to 50 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.